{
    "organizations": [],
    "uuid": "4bca207175ddfacb8eff2b1110d2985968ba5fa5",
    "author": "",
    "url": "https://www.reuters.com/article/brief-trillium-therapeutics-reports-annu/brief-trillium-therapeutics-reports-annual-2017-financial-and-operating-results-idUSASB0C9O2",
    "ord_in_thread": 0,
    "title": "BRIEF-Trillium Therapeutics Reports Annual 2017 Financial And Operating Results",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 9, 2018 / 12:09 PM / in 15 minutes BRIEF-Trillium Therapeutics Reports Annual 2017 Financial And Operating Results Reuters Staff March 9 (Reuters) - Trillium Therapeutics Inc: * TRILLIUM THERAPEUTICS REPORTS ANNUAL 2017 FINANCIAL AND OPERATING RESULTS * TRILLIUM THERAPEUTICS - AS OF DEC 31, 2017, CO HAD CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $81.8 MILLION Source text for Eikon:  ",
    "published": "2018-03-09T14:09:00.000+02:00",
    "crawled": "2018-03-09T14:31:34.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "minute",
        "therapeutic",
        "report",
        "annual",
        "financial",
        "operating",
        "result",
        "reuters",
        "staff",
        "march",
        "reuters",
        "trillium",
        "therapeutic",
        "inc",
        "trillium",
        "therapeutic",
        "report",
        "annual",
        "financial",
        "operating",
        "result",
        "trillium",
        "therapeutic",
        "dec",
        "co",
        "cash",
        "cash",
        "equivalent",
        "marketable",
        "security",
        "million",
        "source",
        "text",
        "eikon"
    ]
}